Intranasal naloxone spray could reduce opioid-related deaths

Naloxone has long been used by emergency responders in cases of known or suspected opioid overdose. It has been accessible over-the-counter (OTC) in an...

Supporting pharmacy interns to administer COVID-19 vaccinations

As a new intern year begins, budding pharmacists around Australia have joined the COVID-19 vaccination effort.

Take Home Naloxone is becoming embedded in pharmacy practice

This International Overdose Awareness Day, pharmacists share how the Take Home Naloxone Program is helping to save patients’ lives.

Managing hand osteoarthritis – the latest evidence

Despite being one of the most common phenotypes with a high clinical burden, hand OA was long regarded as a ‘forgotten disease’, with limited clinical evidence to guide treatment recommendations.

Huge change to vaping laws to smash recreational use

Huge changes are coming to vaping laws. What is changing, and what changes will affect pharmacists?

Preparing for the NSW pharmacy prescribing pilot

From 15 May 2023, women in NSW can access treatment for uncomplicated urinary tract infections through the pharmacy prescribing pilot.